258 related articles for article (PubMed ID: 29813121)
1. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.
Gu L; Wang Z; Zuo J; Li H; Zha L
PLoS One; 2018; 13(5):e0198223. PubMed ID: 29813121
[TBL] [Abstract][Full Text] [Related]
2. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
3. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
Zhang Z; Ma J; Li N; Sun N; Wang C
Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of NF-κB-p65 and phosphorylated NF-κB-p105 is associated with poor prognosis in surgically resectable non-small cell lung cancer.
Lin G; Li C; Huang C; Zhuang W; Huang Y; Xu H; Miao Q; Hu D
J Cell Mol Med; 2018 Mar; 22(3):1923-1930. PubMed ID: 29363879
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
Yang YL; Chen MW; Xian L
PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
7. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Qian HH; Xu TS; Cai XQ; Ji TL; Guo HX
Clin Chim Acta; 2015 Dec; 451(Pt B):208-14. PubMed ID: 25661085
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of ribonucleotide reductase subunit M1 (RRM1) in non-small cell lung cancer: A meta-analysis.
Zhu CM; Lian XY; Bi YH; Hu CC; Liang YW; Li QS
Clin Chim Acta; 2018 Oct; 485():67-73. PubMed ID: 29803896
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
11. VEGF-C in non-small cell lung cancer: meta-analysis.
Jiang H; Shao W; Zhao W
Clin Chim Acta; 2014 Jan; 427():94-9. PubMed ID: 24144865
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis.
Jing W; Li N; Wang Y; Liu X; Liao S; Chai H; Tu J
Oncotarget; 2017 Jan; 8(3):3957-3968. PubMed ID: 27992369
[TBL] [Abstract][Full Text] [Related]
15. Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines.
Baby J; Pickering BF; Vashisht Gopal YN; Van Dyke MW
Cancer Lett; 2007 Sep; 255(1):85-94. PubMed ID: 17493745
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
Zhao J; Shi X; Wang T; Ying C; He S; Chen Y
Cell Physiol Biochem; 2017; 43(2):697-704. PubMed ID: 28946136
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non- Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
Selvaraj G; Kaliamurthi S; Lin S; Gu K; Wei DQ
Curr Med Chem; 2019; 26(42):7694-7713. PubMed ID: 30182835
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis.
Zhang H; Gao L; Zhang B; Zhang L; Wang C
Sci Rep; 2016 Mar; 6():22618. PubMed ID: 26939789
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Li S; Lai Y; Fan J; Shen C; Che G
Clin Exp Med; 2017 May; 17(2):161-174. PubMed ID: 27099933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
